GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
59.45
-1.48 (-2.43%)
At close: May 14, 2025, 4:00 PM
59.41
-0.04 (-0.07%)
After-hours: May 14, 2025, 7:45 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $1.70 billion as of May 14, 2025. Its market cap has increased by 487.62% in one year.
Market Cap
1.70B
Enterprise Value
1.65B
1-Year Change
487.62%
Ranking
Category
Stock Price
$59.45
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $1.70B, a decrease of -90.52%. That is a compound annual growth rate of -40.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 1.74B | -17.66% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |